Aadi Bioscience

Pacific Palisades, CA, United States

1

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by Aadi Bioscience

FDA Drug Class III Terminated

Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.

October 13, 2022 Aadi Bioscience 2,333 vials units